Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises O2 in connection with its application for listing on NASDAQ OMX Stockholm
Mandate

Vinge advises O2 in connection with its application for listing on NASDAQ OMX Stockholm

March 09, 2010

Vinge is advising the wind power company OM Vind AB in connection with the company’s application for listing on NASDAQ OMX Stockholm. The expected first day of trading is 22 March 2010. A new issue of not less than MSEK 950 and not more than MSEK 1,150 will be performed in conjunction with the listing. SEB Enskilda and Swedbank Markets are Joint Lead Managers and Book Runners in the offering. Vinge is also advising on the restructuring of O2’s legal structure which will take place prior to O2’s shares being admitted to trading. Vinge has also advised O2 in connection with negotiation of loan agreements in the amount of approximately SEK 2.4 billion with a Nordic bank consortium consisting of DnB Nor, SEB and Swedbank.

Vinge’s team primarily consists of Lena Almefelt, Petter Alberts, Fredrik Stjernström, Helena Backlund, Christian Johansson, Johan Cederblad, Kimmie Johansson and Andreas Wirén. As regards the loan financing aspect of the transaction, Vinge’s team primarily consists of Mikael Ståhl, Christian Johansson and Ulrica Åkesson.

Related

Vinge advises Fortinova Fastigheter AB (publ) on its first SEK 200 million green bond issue

 Vinge has advised Fortinova Fastigheter AB (publ) (“Fortinova”) on the company’s first issue of senior unsecured green bonds in an aggregate principal amount of SEK 200 million, under a framework of up to SEK 600 million. Nordea, acted as sole bookrunner in connection with the bond issue.
September 18, 2026

Vinge advises Morrow Bank AB (publ) in connection with the bank’s sale of parts of MedMera Bank and the sale of NPL portfolios

 Vinge has advised Morrow Bank AB (publ) in connection with the divestment of parts of MedMera Bank’s operations to a leading global credit investment firm. The divestment is structured as a sale of shares and priced at a premium of approximately SEK 90 million above equity value as per the completion date. The transaction includes parts of MedMera’s banking operations such as IT infrastructure, organisation and management, whilst Morrow Bank retains MedMera’s performing loans, deposits, customers, the MedMera brand, the Coop partnership agreement as well as key personnel.
September 15, 2026

Vinge advises HealthCap in conjunction with its investment in AMRA Medical

 HealthCap is investing in AMRA Medical AB, a company that analyses whole-body MRI images to classify and quantify an individual’s muscle and fat tissue throughout the body and places this in relation to human health and disease.
September 15, 2026